{"log_id": 767267203821762176, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 1.7e-05, "average": 0.997548, "min": 0.987651}, "location": {"width": 111, "top": 240, "height": 26, "left": 242}, "words": "分子量:853"}, {"probability": {"variance": 0.00618, "average": 0.980054, "min": 0.596682}, "location": {"width": 475, "top": 281, "height": 33, "left": 239}, "words": "全部辅料:聚氧乙基-35-蓖麻油,无水柠檬酸,乙醇"}, {"probability": {"variance": 0.079046, "average": 0.798691, "min": 0.401088}, "location": {"width": 54, "top": 324, "height": 27, "left": 243}, "words": "性状"}, {"probability": {"variance": 9e-06, "average": 0.997934, "min": 0.989073}, "location": {"width": 214, "top": 366, "height": 27, "left": 240}, "words": "本品为淡黄色澄明液体"}, {"probability": {"variance": 5e-06, "average": 0.997807, "min": 0.994578}, "location": {"width": 67, "top": 408, "height": 24, "left": 245}, "words": "适应症"}, {"probability": {"variance": 1.2e-05, "average": 0.99754, "min": 0.987756}, "location": {"width": 292, "top": 448, "height": 27, "left": 238}, "words": "进展期卵巢癌的一线和后继治疗"}, {"probability": {"variance": 0.000714, "average": 0.992223, "min": 0.868405}, "location": {"width": 627, "top": 486, "height": 36, "left": 238}, "words": "淋巴结阳性的乳腺癌患者在含阿霉素标准方案联合化疗后的辅助治疗"}, {"probability": {"variance": 1e-06, "average": 0.999176, "min": 0.996271}, "location": {"width": 628, "top": 527, "height": 36, "left": 236}, "words": "转移性乳腺癌联合化疗失败或者辅助化疗6个月内复发的乳腺癌患者"}, {"probability": {"variance": 2e-05, "average": 0.997867, "min": 0.982579}, "location": {"width": 272, "top": 570, "height": 29, "left": 237}, "words": "非小细胞肺癌患者的一线治疗"}, {"probability": {"variance": 0.01233, "average": 0.96493, "min": 0.503536}, "location": {"width": 403, "top": 610, "height": 34, "left": 236}, "words": "艾滋病(AIDS)相关性卡波氏肉瘤( Kaposi"}, {"probability": {"variance": 1.7e-05, "average": 0.995633, "min": 0.989306}, "location": {"width": 105, "top": 619, "height": 25, "left": 746}, "words": "的二线治疗"}, {"probability": {"variance": 0, "average": 0.997906, "min": 0.997325}, "location": {"width": 48, "top": 655, "height": 24, "left": 244}, "words": "规格"}, {"probability": {"variance": 0.000144, "average": 0.988267, "min": 0.958601}, "location": {"width": 128, "top": 697, "height": 24, "left": 237}, "words": "30mg/5mL/瓶"}, {"probability": {"variance": 0.026715, "average": 0.928493, "min": 0.407665}, "location": {"width": 149, "top": 738, "height": 23, "left": 239}, "words": "150mg25mL/瓶"}, {"probability": {"variance": 0.046707, "average": 0.887804, "min": 0.455596}, "location": {"width": 98, "top": 775, "height": 27, "left": 239}, "words": "用法用量1"}, {"probability": {"variance": 6e-06, "average": 0.998471, "min": 0.987944}, "location": {"width": 690, "top": 815, "height": 35, "left": 268}, "words": "注意:不提倡将未经稀释的浓缩药液接触用于配制滴注溶液的增塑聚氯乙烯"}, {"probability": {"variance": 0.013888, "average": 0.955844, "min": 0.5242}, "location": {"width": 768, "top": 853, "height": 62, "left": 246}, "words": "(Vc)器皿。为减少患者接触到可能由聚氯乙烯的滴注袋或其他装置释出的"}, {"probability": {"variance": 0.022864, "average": 0.885905, "min": 0.589954}, "location": {"width": 792, "top": 885, "height": 55, "left": 234}, "words": "DEHP塑料物质[二一(2-乙基己基)邻苯二甲酸酯,di-(2- ethylhexyl)phthalate"}, {"probability": {"variance": 3.4e-05, "average": 0.9978, "min": 0.967449}, "location": {"width": 805, "top": 939, "height": 54, "left": 231}, "words": "稀释后溶液应贮藏在玻璃瓶、聚丙烯瓶或(聚丙烯、聚烯烃类)塑料袋滴注时"}, {"probability": {"variance": 0.000325, "average": 0.993035, "min": 0.933469}, "location": {"width": 252, "top": 982, "height": 25, "left": 233}, "words": "采用聚乙烯衬里的给药设备"}, {"probability": {"variance": 2e-06, "average": 0.998007, "min": 0.996141}, "location": {"width": 88, "top": 1022, "height": 25, "left": 268}, "words": "预防用药"}, {"probability": {"variance": 0.007608, "average": 0.983761, "min": 0.490366}, "location": {"width": 685, "top": 1060, "height": 37, "left": 269}, "words": "为了防止发生严重的过敏反应,接受本品治疗的所有患者应事先进行预防用"}, {"probability": {"variance": 0, "average": 0.819437, "min": 0.819437}, "location": {"width": 26, "top": 1074, "height": 27, "left": 961}, "words": "0"}, {"probability": {"variance": 0.000423, "average": 0.995128, "min": 0.87254}, "location": {"width": 723, "top": 1101, "height": 36, "left": 230}, "words": "药,通常在用本品治疗之前12及6小时左右给予地塞米松20mg口服,或在用本"}, {"probability": {"variance": 0.009192, "average": 0.975466, "min": 0.440027}, "location": {"width": 677, "top": 1141, "height": 37, "left": 227}, "words": "品之前30~60分钟左右静脉滴注地塞米松20mg;苯海拉明(或其同类药)50"}, {"probability": {"variance": 0.04149, "average": 0.760144, "min": 0.486099}, "location": {"width": 97, "top": 1183, "height": 48, "left": 902}, "words": "西达R"}, {"probability": {"variance": 0.00979, "average": 0.960845, "min": 0.506508}, "location": {"width": 746, "top": 1185, "height": 32, "left": 229}, "words": "在用本品之前30~60分钟静注,以及在注射本品之前30-60分钟给子静脉滴注西"}, {"probability": {"variance": 5.5e-05, "average": 0.995766, "min": 0.970195}, "location": {"width": 355, "top": 1227, "height": 26, "left": 227}, "words": "咪替丁(300mg)或雷尼替丁(50mg)"}, {"probability": {"variance": 0.040072, "average": 0.884302, "min": 0.537581}, "location": {"width": 161, "top": 1213, "height": 42, "left": 862}, "words": "华广东含"}, {"probability": {"variance": 0, "average": 0.99956, "min": 0.99928}, "location": {"width": 45, "top": 1268, "height": 23, "left": 267}, "words": "剂量"}, {"probability": {"variance": 1.2e-05, "average": 0.998189, "min": 0.990481}, "location": {"width": 195, "top": 1238, "height": 59, "left": 794}, "words": "医药有限公司"}, {"probability": {"variance": 0, "average": 0.99936, "min": 0.998273}, "location": {"width": 319, "top": 1307, "height": 31, "left": 268}, "words": "对卵巢癌患者,推荐使用下列疗法"}, {"probability": {"variance": 0, "average": 0.745407, "min": 0.745407}, "location": {"width": 84, "top": 1302, "height": 32, "left": 891}, "words": "※"}, {"probability": {"variance": 0.001635, "average": 0.991976, "min": 0.759839}, "location": {"width": 685, "top": 1349, "height": 33, "left": 266}, "words": "1.对于未治疗过的卵巢癌患者,推荐选择使用下列疗法,每3周1次。在选"}, {"probability": {"variance": 3e-06, "average": 0.998751, "min": 0.994898}, "location": {"width": 359, "top": 1389, "height": 29, "left": 226}, "words": "择合适的疗法前,应考虑其不同的毒性"}, {"probability": {"variance": 0.000257, "average": 0.992046, "min": 0.907157}, "location": {"width": 675, "top": 1430, "height": 39, "left": 277}, "words": "(1)静脉滴注175mg/m2,滴注时间大于3小时,并给予顺铂75mg/m2;或"}], "language": 3}